Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy

Madeleine J Bunders1, Olivier Frinking, Henriette J Scherpbier

  • 1Department of Paediatric Immunology, Haematology, and Infectious Diseases, Emma Children Hospital, Amsterdam, The Netherlands. m.j.bunders@amc.uva.nl

Insights

Combination antiretroviral therapy (cART) for children with human immunodeficiency virus (HIV) may affect bone health. Long-term data reveal that cumulative cART positively impacts bone mineral density (BMD) over time in these children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Endocrinology

Background:

  • Long-term management of human immunodeficiency virus (HIV) in children involves combination antiretroviral therapy (cART).
  • Potential adverse effects of cART, including impacts on bone health, require ongoing evaluation.
  • Osteoporosis is a significant concern in HIV-infected populations.

Purpose of the Study:

  • To assess the long-term effects of combination antiretroviral therapy (cART) on bone mineral density (BMD) in children with HIV.
  • To evaluate the relationship between cumulative cART exposure and BMD changes over time.

Main Methods:

  • Longitudinal study design.
  • Collection and analysis of bone mineral density (BMD) data in HIV-infected children.
  • Assessment of cumulative combination antiretroviral therapy (cART) exposure.

Main Results:

  • Longitudinal data demonstrated a positive impact of cumulative cART on bone mineral density (BMD) over time.
  • Analysis indicated that extended treatment with cART is associated with improved BMD in HIV-infected children.

Conclusions:

  • Combination antiretroviral therapy (cART) appears to have a beneficial effect on bone mineral density (BMD) in children with HIV.
  • Long-term cART may mitigate some of the bone-related adverse effects in pediatric HIV infection.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...